A Case of Pleural Tuberculosis vs Latent Tuberculosis Reactivation as a Result of COVID-19 Infection and Treatment

The reactivation of latent tuberculosis occurs when a patient living with Mycobacterium tuberculosis enters a state where the immune system is suppressed. Since early 2021, the standard of care has been to provide corticosteroids in patients with COVID-19 infection in hospitalized patients receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Wesley, Leonhardt, Lex, Pervez, Aamir, Sarvepalli, Satish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Greater Baltimore Medical Center 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533800/
https://www.ncbi.nlm.nih.gov/pubmed/36262898
http://dx.doi.org/10.55729/2000-9666.1078
_version_ 1784802421003780096
author Tang, Wesley
Leonhardt, Lex
Pervez, Aamir
Sarvepalli, Satish
author_facet Tang, Wesley
Leonhardt, Lex
Pervez, Aamir
Sarvepalli, Satish
author_sort Tang, Wesley
collection PubMed
description The reactivation of latent tuberculosis occurs when a patient living with Mycobacterium tuberculosis enters a state where the immune system is suppressed. Since early 2021, the standard of care has been to provide corticosteroids in patients with COVID-19 infection in hospitalized patients receiving supplemental oxygen or mechanical ventilation. The immunomodulatory effects of corticosteroids are potentially detrimental for patients with latent vs active tuberculosis, with concomitant SARS-CoV2 infection. We present one of the first few cases in the literature detailing a case of reactivation of latent tuberculosis vs. pleural tuberculosis as a consequence of COVID-19, and who underwent subsequent corticosteroid treatment.
format Online
Article
Text
id pubmed-9533800
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Greater Baltimore Medical Center
record_format MEDLINE/PubMed
spelling pubmed-95338002022-10-18 A Case of Pleural Tuberculosis vs Latent Tuberculosis Reactivation as a Result of COVID-19 Infection and Treatment Tang, Wesley Leonhardt, Lex Pervez, Aamir Sarvepalli, Satish J Community Hosp Intern Med Perspect Case Report The reactivation of latent tuberculosis occurs when a patient living with Mycobacterium tuberculosis enters a state where the immune system is suppressed. Since early 2021, the standard of care has been to provide corticosteroids in patients with COVID-19 infection in hospitalized patients receiving supplemental oxygen or mechanical ventilation. The immunomodulatory effects of corticosteroids are potentially detrimental for patients with latent vs active tuberculosis, with concomitant SARS-CoV2 infection. We present one of the first few cases in the literature detailing a case of reactivation of latent tuberculosis vs. pleural tuberculosis as a consequence of COVID-19, and who underwent subsequent corticosteroid treatment. Greater Baltimore Medical Center 2022-07-04 /pmc/articles/PMC9533800/ /pubmed/36262898 http://dx.doi.org/10.55729/2000-9666.1078 Text en © 2022 Greater Baltimore Medical Center https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ).
spellingShingle Case Report
Tang, Wesley
Leonhardt, Lex
Pervez, Aamir
Sarvepalli, Satish
A Case of Pleural Tuberculosis vs Latent Tuberculosis Reactivation as a Result of COVID-19 Infection and Treatment
title A Case of Pleural Tuberculosis vs Latent Tuberculosis Reactivation as a Result of COVID-19 Infection and Treatment
title_full A Case of Pleural Tuberculosis vs Latent Tuberculosis Reactivation as a Result of COVID-19 Infection and Treatment
title_fullStr A Case of Pleural Tuberculosis vs Latent Tuberculosis Reactivation as a Result of COVID-19 Infection and Treatment
title_full_unstemmed A Case of Pleural Tuberculosis vs Latent Tuberculosis Reactivation as a Result of COVID-19 Infection and Treatment
title_short A Case of Pleural Tuberculosis vs Latent Tuberculosis Reactivation as a Result of COVID-19 Infection and Treatment
title_sort case of pleural tuberculosis vs latent tuberculosis reactivation as a result of covid-19 infection and treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533800/
https://www.ncbi.nlm.nih.gov/pubmed/36262898
http://dx.doi.org/10.55729/2000-9666.1078
work_keys_str_mv AT tangwesley acaseofpleuraltuberculosisvslatenttuberculosisreactivationasaresultofcovid19infectionandtreatment
AT leonhardtlex acaseofpleuraltuberculosisvslatenttuberculosisreactivationasaresultofcovid19infectionandtreatment
AT pervezaamir acaseofpleuraltuberculosisvslatenttuberculosisreactivationasaresultofcovid19infectionandtreatment
AT sarvepallisatish acaseofpleuraltuberculosisvslatenttuberculosisreactivationasaresultofcovid19infectionandtreatment
AT tangwesley caseofpleuraltuberculosisvslatenttuberculosisreactivationasaresultofcovid19infectionandtreatment
AT leonhardtlex caseofpleuraltuberculosisvslatenttuberculosisreactivationasaresultofcovid19infectionandtreatment
AT pervezaamir caseofpleuraltuberculosisvslatenttuberculosisreactivationasaresultofcovid19infectionandtreatment
AT sarvepallisatish caseofpleuraltuberculosisvslatenttuberculosisreactivationasaresultofcovid19infectionandtreatment

Ejemplares similares